Resveratrol limits epithelial to mesenchymal transition through modulation of KHSRP/hnRNPA1-dependent alternative splicing in mammary gland cells
- 1 March 2017
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1860 (3) , 291-298
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (15195)
- Italian Ministero della Salute 5xmille 2013 (S361A)
This publication has 28 references indexed in Scilit:
- Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasisToxicology, 2013
- Py2T Murine Breast Cancer Cells, a Versatile Model of TGFβ-Induced EMT In Vitro and In VivoPLOS ONE, 2012
- Bone Morphogenetic Protein/SMAD Signaling Orients Cell Fate Decision by Impairing KSRP-Dependent MicroRNA MaturationCell Reports, 2012
- Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)Seminars in Cancer Biology, 2012
- Fibroblast Growth Factor Receptor 2 IIIc as a Therapeutic Target for Colorectal Cancer CellsMolecular Cancer Therapeutics, 2012
- Integrative Genome-wide Analysis Reveals Cooperative Regulation of Alternative Splicing by hnRNP ProteinsCell Reports, 2012
- Resveratrol, by Modulating RNA Processing Factor Levels, Can Influence the Alternative Splicing of Pre-mRNAsPLOS ONE, 2011
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progressionJournal of Clinical Investigation, 2011
- Induction of full-length survival motor neuron by polyphenol botanical compoundsHuman Genetics, 2007
- p38-Dependent Phosphorylation of the mRNA Decay-Promoting Factor KSRP Controls the Stability of Select Myogenic TranscriptsMolecular Cell, 2005